So-called special purpose acquisition companies represent a new phase in the corporatization of medicine, and their activities could have implications for providers, patients, and policymakers.

中文翻译：

---

Corporate Medicine 2.0——美国的特殊目的收购公司

所谓的特殊目的收购公司代表了医药公司化的新阶段，它们的活动可能对提供者、患者和政策制定者产生影响。